Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
42,965,286
-
Share change
-
+1,840,935
-
Total reported value
-
$1,115,314,779
-
Put/Call ratio
-
29%
-
Price per share
-
$25.96
-
Number of holders
-
200
-
Value change
-
+$58,290,313
-
Number of buys
-
101
-
Number of sells
-
83
Institutional Holders of MERIDIAN BIOSCIENCE INC - COMMON STOCK (VIVO) as of Q1 2022
As of 31 Mar 2022,
MERIDIAN BIOSCIENCE INC - COMMON STOCK (VIVO) was held by
200 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,965,286 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Impactive Capital LP, EARNEST PARTNERS LLC, ROYCE & ASSOCIATES LP, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, KEMPEN CAPITAL MANAGEMENT N.V., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
200
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.